BioCardia, Inc. (BCDA): Nasdaq/NYSE listing notice — BioCardia: Nasdaq notice for equity $837K vs $2.5M minimum; plan due May 16

BioCardia, Inc.

Stockholders' equity of $837K as of Dec 31, 2024 is below Nasdaq's $2.5M minimum for continued listing.
Company must submit a compliance plan by May 16, 2025; Nasdaq may grant up to 180-day extension.
No immediate effect on trading; common stock continues on Nasdaq Capital Market under BCDA.
Company intends to submit a plan; risk of delisting if plan rejected or not accepted.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

BioCardia, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5550(b)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5550(b)(1)

Exact text from the filing

December 31, 2024, it is no longer in compliance with the minimum stockholders’ equity requirement of $2.5 million for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1). The Company has until May 16, 2025 to provide Nasdaq with a plan to regain compliance with the foregoing listing requirement. If the Company’s plan to regain compliance is accepted, Nasdaq may grant an extension of up to 180 calendar days from April 1, 2025 for the Company to evidence compliance. The Notice has no immediate effect on the listing or trading of the Company’s common stock and the

View on SEC.gov

Browse all listing & compliance notices →

BioCardia, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-011030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.